Zhang, G., Cheng, R., Zhang, Z., Jiang, T., Ren, S., Ma, Z., . . . Zhang, J. (2017). Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases. Sci Rep.
Citação norma ChicagoZhang, Guowei, Ruirui Cheng, Zengli Zhang, Tao Jiang, Shengxiang Ren, Zhiyong Ma, Sha Zhao, Caicun Zhou, and Jun Zhang. "Bisphosphonates Enhance Antitumor Effect of EGFR-TKIs in Patients With Advanced EGFR Mutant NSCLC and Bone Metastases." Sci Rep 2017.
Citação norma MLAZhang, Guowei, et al. "Bisphosphonates Enhance Antitumor Effect of EGFR-TKIs in Patients With Advanced EGFR Mutant NSCLC and Bone Metastases." Sci Rep 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.